Close Menu

UK government

New UKRI Head Named

ScienceInsider reports the University of Cambridge's Ottoline Leyser is to take over UK Research and Innovation.

Illumina will sequence 35,000 whole genomes for the Genetics of Mortality in Critical Care (GenOMICC) study and will provide an in-kind contribution.

The UK has had to send samples to the US for coronavirus testing, according to the Telegraph.

SAGE Names Released

The Guardian reports that the UK government has released the names of dozens of members of the Scientific Advisory Group for Emergencies.

New Scientist reports the names of the members of the Scientific Advisory Group for Emergencies that is advising the UK on its coronavirus response are to be released.

Tell You Later

Data and documents guiding the UK response to COVID-19 won't be released until the pandemic is under control, New Scientist reports.

Not Usable

The UK spent $20 million on antibody tests for SARS-CoV-2 that did not work, the New York Times reports.

Behind on Testing

An opinion piece at the Guardian discusses the state of SARS-CoV-2 testing in the UK.

Extension Call

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

FIND will use the funding to support the development of rapid tests, especially in low- and middle-income countries.

Pages

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.